Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Perindopril shows no effect on postural balance of older adults at risk of falls

15 Aug 2017

The angiotensin converting enzyme (ACE) inhibitor perindopril does not appear to improve postural sway in older individuals at risk of falls, according to a study. Despite the lack of effect on postural balance, the drug does not worsen the rate of falls or orthostatic hypotension (OH).

A total of 80 individuals aged >65 years (mean 78 years; 75 percent female) with at least one fall event in the previous 12 months were randomized to receive 4 mg perindopril or placebo daily for 15 weeks. Force-plate measured anteroposterior (AP) sway at 15 weeks was the primary outcome. Measures of postural sway, limits of stability (during maximal forward, right and left leaning), blood pressure, muscle strength, 6-min walk distance and falls were also evaluated as secondary outcomes.

Of the participants, 77 (96 percent) completed the trial. There were no significant differences between the perindopril or placebo groups in terms of AP sway with eyes open (mean difference, 0 mm; 95 percent CI, −8 to 7; p=0.91) or eyes closed (mean difference, 2 mm; −7 to 12 mm; p=0.59). Likewise, no between-group differences were seen in other measures of postural stability, muscle strength or function.

At follow-up, OH was reported in about 42 percent of patients in each treatment group. The median number of falls was 1 (interquartile range, 0 to 4) in the perindopril group vs 1 (0 to 2) in the placebo group (p=0.24).

Findings of the current study “do not support a strategy of using ACE inhibitors to reduce falls in older people with a history of falls, but they equally suggest that [the drugs] may not have a deleterious effect on key risks for falls, including OH,” researchers said.

“There may therefore be little to gain by stopping ACE inhibitors in those who fall, particularly if other indications for [the drugs] (eg, heart failure, previous stroke or other vascular event) are present,” they added.

More research is needed to further clarify the effect of ACE inhibitors on falls risk in elderly individuals.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.